| Therapeutic lifestyle changes and pharmaceutical care in the treatment of dyslipidemias in adults. | |
| | |
MedLine Citation:
|
PMID: 16128506 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To review each therapeutic lifestyle change (TLC) component listed in the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) cholesterol guidelines and discuss how the guidelines can be used by pharmacists in the treatment of patients with dyslipidemias. DATA SOURCES: Published guidelines and abstracts identified through PubMed (May 1987-March 2004), Medline (January 1966-March 2004), using the search terms cholesterol, hypercholesterolemia, dyslipidemia, hyperlipidemia, diet, saturated fats, unsaturated fats, trans-fatty acids, overweight, obese, exercise, physical activity, program adherence, and guidelines; as well as the NCEP ATP III guidelines, the 2004 ATP III update, National Heart, Lung, and Blood Institute Obesity Guidelines, and Dietary Guidelines for Americans 2005. STUDY SELECTION: Performed manually by author. DATA EXTRACTION: Performed manually by author. DATA SYNTHESIS: TLC components are recommended in the NCEP ATP III guidelines for treatment of patients with dyslipidemias independent of medication use. Dietary modifications are the primary focus of TLC therapy. Saturated fat intake should be limited to less than 7% of total caloric intake and trans-fatty acid intake should be low for patients with dyslipidemias. Persons who are overweight or obese with dyslipidemias should reduce body weight through a combination of physical activity, total calorie reduction, and behavior therapy modifications. CONCLUSION: Pharmacists, given the proper training, can be effective at offering preventive pharmaceutical care for decreasing high blood cholesterol and the risk for coronary heart disease through patient counseling on TLC components as well as drug therapy in patients with dyslipidemias. |
| | |
Authors:
|
Thomas L Lenz |
Related Documents
:
|
7627786 - Implementing new dietary guidelines of the national cholesterol education program. 22460246 - Influence of genetic variants in the apolipoprotein a5 and c3 gene on lipids, lipoprote... 15749436 - Orbitofrontal cholesterol granuloma. 16303026 - Mortality patterns in infectious salmon anaemia virus outbreaks in new brunswick, canada. 7568286 - Tissue distribution of alpha-tocopherol following dietary supplementation in the rat: e... 17191066 - The relationship between blood serum lipids and periodontal condition. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Journal of the American Pharmacists Association : JAPhA Volume: 45 ISSN: 1544-3191 ISO Abbreviation: J Am Pharm Assoc (2003) Publication Date: 2005 Jul-Aug |
Date Detail:
|
Created Date: 2005-08-30 Completed Date: 2006-05-30 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 101176252 Medline TA: J Am Pharm Assoc (2003) Country: United States |
Other Details:
|
Languages: eng Pagination: 492-9; quiz 500-2 Citation Subset: IM |
Affiliation:
|
Department of Pharmacy Practice, School of Pharmacy and Health Professions, Creighton University Medical Center, 2500 California Plaza, Omaha, NE 68178, USA. tlenz@creighton.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Community Pharmacy Services / standards*, trends Dyslipidemias / therapy* Education, Pharmacy, Continuing Humans Life Style* Pharmaceutical Services / standards*, trends Practice Guidelines as Topic / standards |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: North Carolina family practice physicians' perceptions of pharmacists as vaccinators.
Next Document: Rosuvastatin: a high-potency HMG-CoA reductase inhibitor.